bdp 12 has been researched along with Autism in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berry-Kravis, E; Block, SS; Cogswell, J; Cook, E; Decle, P; Guter, S; Hagerman, R; Jardini, T; Johnson, SA; Krause, SE; Lara, R; Leurgans, S; Maino, D; Potanos, K; Salt, J; Weinberg, D; Wuu, J | 1 |
1 trial(s) available for bdp 12 and Autism
Article | Year |
---|---|
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial.
Topics: Adolescent; Adult; Autistic Disorder; Child Behavior Disorders; Cognition Disorders; Dioxoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Eruptions; Female; Fragile X Syndrome; Humans; Long-Term Potentiation; Male; Neuronal Plasticity; Neuropsychological Tests; Personality Assessment; Piperidines; Receptors, AMPA; Synaptic Transmission; Treatment Outcome | 2006 |